Neither testosterone pellets nor injections are universally superior — the better choice depends on the individual patient’s lifestyle, tolerance for hormonal fluctuation, cost constraints, and fertility considerations. Injections offer precise dose control, easy adjustment, and lowest cost. Pellets offer convenience and stable levels without weekly administration. Both deliver therapeutic testosterone effectively in confirmed hypogonadism, but they differ substantially in pharmacokinetics, side effect profile, reversibility, and practical management. Understanding these differences is the foundation of an informed treatment decision.
How Each Delivery Method Works
Injectable testosterone
Injectable testosterone is administered as an oil-based solution subcutaneously or intramuscularly into the thigh, glute, or abdomen. The most commonly prescribed esters in the United States are testosterone cypionate and testosterone enanthate, both with half-lives of approximately 7 to 8 days. A typical protocol involves weekly or biweekly self-injection at home following an initial training session with a nurse or physician.
After injection, testosterone releases from the oil depot at a predictable rate, producing a peak in serum levels at 24 to 72 hours and a trough before the next injection. Weekly injection intervals minimize peak-trough variability compared to biweekly dosing. Some protocols use twice-weekly or every-three-day injection schedules to further reduce the hormonal swing and estradiol conversion that accompanies higher testosterone peaks.
Testosterone pellets
Testosterone pellets (Testopel is the FDA-approved brand; compounded pellets are also widely used) are cylindrical implants approximately 3mm in diameter and 9mm in length, each containing 75mg of crystalline testosterone. During an in-office procedure under local anesthesia, a physician inserts 6 to 12 pellets (450mg to 900mg total) into the subcutaneous fat of the upper buttock or hip via a trocar. The pellets dissolve over 3 to 6 months through surface-area-driven diffusion, providing stable testosterone release without injections during that period.
The number of pellets inserted is calculated based on body weight, baseline testosterone level, and activity level. Once inserted, pellets cannot be removed or adjusted. Testosterone levels begin rising within days, peak at 4 to 6 weeks, and decline as pellets dissolve. Re-insertion is required when symptoms return, typically at the 3 to 5 month mark depending on individual metabolism.
Testopel (testosterone pellets) is FDA-approved for hypogonadism in men. However, many clinics use compounded testosterone pellets rather than Testopel, as they are less expensive and allow custom dosing. Compounded pellets are not FDA-approved and have not undergone the same quality, sterility, and consistency review as Testopel. If you are receiving pellets, ask your provider whether they are using FDA-approved Testopel or a compounded alternative.
Pharmacokinetics: Stable Levels vs. Controllable Delivery
The pharmacokinetic differences between pellets and injections are clinically significant and drive most of the practical differences patients experience.
Pharmacokinetic Profile: Pellets vs. Injections
For men sensitive to hormonal fluctuation — those who notice mood changes, libido variation, or energy swings through their injection cycle — pellets offer an advantage through their stable delivery profile. For men who respond well to injections and prefer cost efficiency and dose control, weekly injections produce outcomes equivalent to pellets at a fraction of the cost. The timing of injections also matters for managing side effects. For more on optimising injection scheduling, see our guide on the best time to inject testosterone.
Direct Comparison: 12 Key Factors
| Factor | Pellets | Injections | Advantage |
|---|---|---|---|
| Cost per month | $133 to $400 (annualized) | $30 to $70 (generic) | Injections |
| Hormonal stability | Highest — steady plateau | Moderate — weekly peak-trough | Pellets |
| Dose adjustability | None after insertion | Full control at any time | Injections |
| Reversibility | Not reversible (pellets dissolve over months) | Stop any injection immediately | Injections |
| Administration burden | Procedure every 3 to 6 months | Weekly self-injection | Pellets |
| Needle anxiety | One procedure; no self-injection | Weekly self-needle required | Pellets |
| Fertility preservation | Not compatible — suppresses HPG axis | Not compatible as monotherapy; hCG can be added | Injections (with hCG) |
| Estradiol management | Stable aromatization; AI less commonly needed | Peak-driven estradiol spikes; AI may be needed | Pellets |
| Infection risk | Low but present (surgical insertion site) | Minimal with proper technique | Injections |
| Polycythemia risk | Lower — stable levels; less erythropoietic peak | Higher with supraphysiologic peaks | Pellets |
| Travel and lifestyle | No supplies, no refrigeration, no schedule | Supplies and scheduling required | Pellets |
| Insurance coverage | Inconsistent — often requires separate PA | Most commonly covered formulation | Injections |
Side Effects: What Differs Between the Two
Both formulations share the core TRT side effect profile: potential for polycythemia, PSA changes, lipid alterations, testicular atrophy, and suppression of spermatogenesis. Several side effects differ meaningfully between the two delivery methods.
Pellet-specific considerations
Pellet extrusion. In approximately 1 to 5% of insertions, a pellet is partially or fully expelled from the insertion site before dissolving, typically in the first 2 to 4 weeks. Extrusion is more common with vigorous physical activity in the days immediately after insertion and can cause underdosing for the remainder of the insertion cycle.
Insertion site complications. Pain, bruising, and minor infection at the insertion site occur in a small percentage of patients. More significant complications (hematoma, abscess) are rare but cannot be managed by stopping the medication as with injections.
No dose correction mid-cycle. If testosterone levels run higher than intended (producing symptoms of excess — acne, irritability, elevated hematocrit), there is no way to reduce the dose. The patient must wait for pellets to dissolve, which can take weeks to months. This is the most clinically significant disadvantage of pellets vs. injections.
Injection-specific considerations
Peak-related symptoms. In the 24 to 72 hours after injection, testosterone peaks significantly above trough levels. This peak drives higher estradiol conversion, which some men experience as water retention, nipple sensitivity, or mood volatility. Switching from biweekly to weekly injections, or from intramuscular to subcutaneous administration, typically reduces peak magnitude and associated symptoms. For guidance on timing strategies that minimize post-injection side effects, see our article on the best time to inject testosterone.
Injection site reactions. With proper technique, injection site reactions are minimal. Rotating sites (bilateral thighs, glutes, or abdomen for subcutaneous) prevents buildup and irritation. Oil embolism from inadvertent intravascular injection is rare but requires proper aspiration technique.
Before choosing pellets, patients and physicians should confirm: (1) the patient has already demonstrated adequate response to testosterone therapy at a known dose, so that dosing can be calibrated for pellet insertion; (2) no plans to change dose or discontinue within the next 3 to 6 months; (3) no active concern about elevated hematocrit or PSA that might require dose reduction; (4) no fertility plans, as pellets suppress spermatogenesis for the full insertion period with no ability to pause.
Pellets are generally not recommended as a first TRT formulation for patients new to therapy. Establishing response and optimal dose on injections before transitioning to pellets is a clinically prudent approach.
Who Is Each Formulation Best Suited For?
Pellets vs. Injections: Ideal Patient Profile
Transitioning Between Formulations
Patients sometimes transition from injections to pellets after establishing their optimal dose, or from pellets back to injections when pellets produce unsatisfactory results or complications.
Injections to pellets
The transition from injections to pellets requires knowing the patient’s established weekly injectable dose to calculate the appropriate total pellet load. A physician will typically continue injections until the day of pellet insertion or taper the final injection in the week before insertion, ensuring levels do not drop significantly during the transition. Monitoring at 4 to 6 weeks post-insertion confirms adequate dosing before the next scheduled follow-up.
Pellets to injections
Transitioning from pellets to injections requires waiting for the current pellet cycle to complete or near-complete, as injecting testosterone on top of active pellets will produce supraphysiologic levels. The physician will typically initiate injections when pellet-driven testosterone levels have declined toward the trough of the pellet cycle (typically after month 4 to 5). Monitoring ensures smooth continuity without gaps in therapeutic coverage.
Men currently on injections who are considering switching to pellets should first ensure their injection protocol is fully optimized. This includes confirming the right dose, the right frequency, and the right administration route (intramuscular vs. subcutaneous). Subcutaneous injections generally produce flatter testosterone curves and fewer estradiol spikes than intramuscular, which addresses some of the stability advantages that make pellets attractive. If the primary motivation for switching to pellets is reducing mood swings or estradiol issues, optimizing the injection protocol may resolve those concerns without the higher cost and irreversibility of pellets. For help with injection protocol questions, see our guide on TRT dosage and injection protocols.
What Other Formulations Are Available?
Pellets and injections are the two most commonly compared formulations, but they are not the only options. Testosterone gels and creams (daily topical application), patches, nasal gels, and oral capsules each have distinct pharmacokinetics and practical profiles. For men who are not suitable for either injections or pellets, a daily gel or cream often provides a practical middle ground: stable levels without injection, adjustable dose without surgical insertion, at a cost between the two.
A full cost comparison across all TRT formulations including insurance coverage considerations is available in our guide on how much TRT costs: complete price breakdown 2026.
Get Started With a Supervised TRT Programme
If you are considering starting testosterone therapy or switching formulations, a physician-supervised evaluation is the appropriate starting point. Advanced TRT Clinic provides comprehensive testosterone evaluation and treatment via telemedicine, including formulation guidance, lab coordination, and ongoing clinical management. Availability varies by state.
